Skip to main content
Medtronic8-K: Digital transformation

Medtronic accelerates commercialization of MiniMed Flex™ pump after early FDA approval, taking a $157M charge.

What happened

The earlier-than-expected FDA clearance for its next-gen smartphone-controlled insulin pump forces an accelerated commercial launch. This creates immediate operational needs in sales, marketing, and supply chain, while a related $157M one-time charge puts short-term pressure on financial performance.

Source

SEC EDGARMar 24, 2026

Current report (Form 8-K)

Medtronic 8-K

Filing excerpt

On March 18, 2026, MiniMed Group, Inc. (MiniMed), a consolidated subsidiary of Medtronic plc (Company) announced that the U.S. Food and Drug Administration (FDA) has cleared the MiniMed Flex™, a next-generation discreet, smartphone-controlled insulin pump.

sec.gov/Archives/edgar/data/1613103/000161310326000005/mdt-20260324.htmRead the full source

Other signals in this filing (5)

Extracted by Autobound

From the Signal API record
Signal
8-K: Digital transformation

What this signalsFilings often name leadership changes, deals and spending plans.

Form
8-K
Fiscal year end
03/24
Filed
Mar 24, 2026

The full record

From the Signal API record

Numbers

Dollar figure
$157M (One-time charge in Q4 FY2026 related to future royalty payments for MiniMed Flex™ development.)

Details

CIK
1613103
Accession number
0001613103-26-000005
Timeframe
Current quarter
Filing year
2026
Why it matters
Multi-year tech investment
Signal category
Strategic

Topics and mentions

Technologies

  • smartphone-controlled devices

Vendors

  • Blackstone Life Sciences Advisors L.L.C.

Regions named

  • U.S.

Extraction

Confidence
High
Relevance
90%
Sentiment
Neutral
Detected
Mar 31, 2026
signal_type
sec-8k
signal_subtype
digitalTransformation

Use this data

Get every 8-K signal for Medtronic and the companies you sell to, in the tools you already use.

  1. Ask Claude about it

    Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Medtronic this week?”

  2. Send it to your own tools

    The Signal API returns 8-K signals for any list of companies as JSON, for your CRM, warehouse or app.

  3. Try it free

    Sign up and spend your free credits on the companies you sell to.

    Start Free1,000 free credits

The API returns more than this page shows

This page shows a preview. The full sec-8k record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.

Company

  • linkedin_urlValue in the API
  • industriesValue in the API
  • employee_count_lowValue in the API
  • employee_count_highValue in the API
  • revenueValue in the API
  • descriptionValue in the API

Signal

  • signal_nameValue in the API
  • associationValue in the API
Show the full JSONThe record on this page and the API request

GET /v1/signals/79c0fb1f-63ba-4ba1-8532-c595b88cad3e returns this record as JSON. POST /v1/companies/enrich returns every signal for medtronic.com.

{
  "signal_id": "79c0fb1f-63ba-4ba1-8532-c595b88cad3e",
  "signal_type": "sec-8k",
  "signal_subtype": "digitalTransformation",
  "detected_at": "2026-03-31T08:16:22.945+00:00",
  "company": {
    "name": "Medtronic",
    "domain": "medtronic.com"
  },
  "data": {
    "detail": "The earlier-than-expected FDA clearance for its next-gen smartphone-controlled insulin pump forces an accelerated commercial launch. This creates immediate operational needs in sales, marketing, and supply chain, while a related $157M one-time charge puts short-term pressure on financial performance.",
    "metrics": {
      "timeframe": "current_quarter",
      "dollar_context": "One-time charge in Q4 FY2026 related to future royalty payments for MiniMed Flex™ development.",
      "dollar_millions": 157
    },
    "summary": "Medtronic accelerates commercialization of MiniMed Flex™ pump after early FDA approval, taking a $157M charge.",
    "excerpts": "On March 18, 2026, MiniMed Group, Inc. (MiniMed), a consolidated subsidiary of Medtronic plc (Company) announced that the U.S. Food and Drug Administration (FDA) has cleared the MiniMed Flex™, a next-generation discreet, smartphone-controlled insulin pump.",
    "relevance": 0.9,
    "sentiment": "neutral",
    "confidence": "high",
    "source_url": "https://www.sec.gov/Archives/edgar/data/1613103/000161310326000005/mdt-20260324.htm",
    "filing_date": "2026-03-24",
    "filing_year": 2026,
    "fiscal_year_end": "03/24",
    "sales_relevance": "Multi-year tech investment",
    "signal_category": "strategic",
    "regions_mentioned": [
      "U.S."
    ],
    "vendors_mentioned": [
      "Blackstone Life Sciences Advisors L.L.C."
    ],
    "technologies_mentioned": [
      "smartphone-controlled devices"
    ]
  }
}

Long text fields are shortened on this page.

Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.